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Abstract. The reorganization from a  radical inter- 
phase microtubule (MT) network into a bipolar spin- 
dle at the onset of mitosis involves a dramatic change 
in MT dynamics. Microtubule-associated proteins 
(MAPs) and other factors are thought to regulate MT 
dynamics both in interphase and in mitosis. In this 
study we report the purification and functional in vitro 
characterization of a  230-KD MAP from Xenopus egg 
extract (XMAP230).  This protein is present in eggs, 
oocytes, testis and a Xenopus tissue culture cell line. It 
is apparently absent from non-dividing cells in which 
an immunologically related 200-kD protein is found. 
XMAP230 is composed of two isoforms with slightly 
different molecular masses and pls.  It is localized to 
interphase MTs, dissociates from MTs at the onset of 
prophase and specifically binds to spindle MTs during 
metaphase and anaphase.  The dissociation constant of 
XMAP230  is 500 nM, the stoichiometry of binding to 
MTs is between 1:8 and  1:4,  and the in vivo concen- 
tration is •200  nM. Both isoforms are phosphorylated 
and have reduced affinity for microtubules in mitotic 
extracts. Analysis of the effect of XMAP230 on MT 
dynamics by video microscopy shows that it increases 
the growth rate, decreases the shrinking rate of MTs 
and strongly suppresses catastrophes. These results 
suggest that in vivo, XMAP230 participates in the 
control of the MT elongation rate, stabilizes MTs and 
locally modulates MT dynamics during mitosis. 
the onset of mitosis, microtubules (MTs) ~  reorganize 
from a radial network into a bipolar spindle. This 
reorganization involves a  dramatic change in mi- 
crotubule dynamics that allows the elimination of the in- 
terphase MTs and the growth of new highly dynamic MTs 
towards chromosomes. Both in interphase and mitosis, MTs 
originate from the centrosome and alternate between grow- 
ing and shrinking phases at various rates (dynamic instabil- 
ity behavior, Kirschner and Mitchison, 1986).  MT growth 
rates (vg) and MT shrinking rates (vs) are fairly similar in 
interphase and mitosis, but the frequency at which they tran- 
sit from growth to  shrinkage (catastrophe  frequency, f,,) 
increases ",~10-fold  during mitosis, and the opposite transi- 
tion  (rescue  frequency,  f~s) is  reduced  (Belmont  et  al., 
1990; Gliksman et al., 1992; Verde et al., 1992). MTs grow 
much faster in vivo than in vitro at similar tubulin concentra- 
tions, and in vivo the value of f,t is high, compared to that 
for pure  MTs  assembled  in  vitro  (Walker  et  al.,  1988). 
Clearly, a  combination of microtubule-associated proteins 
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(MAPs) and other factors regulate MT dynamics in vivo. 
Most of our knowledge of MAPs comes from studies on this 
type of molecule isolated from brain,  that is,  from non- 
dividing cells. Brain MAPs stabilize MTs, although video 
microscopy has only been used to study the mechanism by 
which they do this for tau and MAP2 (Drechsel et al., 1992; 
Pryer et al., 1992). In non-neuronal cells, the best character- 
ized MAP is MAP4 (Parysek et al., 1984).  Members of the 
MAP4 family have been found in mouse, rat and bovine cells 
(Parysek et al., 1984; Bloom et al., 1985; Murofushi et al., 
1986).  Early studies on the in vivo function of MAP4 have 
been limited to a demonstration of mitotic arrest in dividing 
HeLa cells injected with mAbs (Izant et al.,  1983).  Data 
from experiments using the antisense technique also indicate 
that MAP4 is required for normal progression through the 
cell cycle (K. R. Olson, and J. B. Olmsted, personal commu- 
nication). 
We know that the change in dynamics observed at the on- 
set of mitosis is induced by the cyclin B-dependent kinase 
(Verde et al.,  1990) but we still do not know the nature of 
the molecules involved in the regulation of MT dynamics 
both during interphase and mitosis in growing ceils. 
To identify proteins involved in mitotic spindle assembly, 
we are currently using Xenopus egg cytoplasmic extracts to 
systematically characterize different MAPs and generate re- 
agents to study their function. We describe the purification 
and biochemical and functional characterization of XMAP- 
230,  one of the Xenopus MAPs we have identified. 
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Materials 
Calf brain tubulin was prepared by two cycles of polymerization and depoly- 
merization followed by phosphocellulose chromatography (Mitchison and 
Kirschner,  1984a,b).  The tubulin we used was incompetent to assemble 
into MTs at concentrations below 30 #M. This was determined by video- 
enhanced interference contrast microscopy, cryo-electron microscopy, and 
turbidimetry. Human centrosomes were prepared from KE37 lymphoblasts 
according to Bornens et al. (1987). Unless indicated, chemicals were from 
Sigma Chem Co. (St. Louis, MO), Merck (Darmstadt, Germany), or Boeh- 
ringer Mannheim GmbH (Mannheim, Germany). 
Preparation of  Xenopus Egg Extracts and 
Purification of  XMAP230 
Interphase extracts used for the purification of XMAP230 were prepared 
90 min after activation of the eggs by an electric shock (12V, AC, 2S) accord- 
ing to F~lix  et al.  (1993),  with the following modifications. Protease in- 
hibitors were added (10 #g/ml aprotinin, pepstatin, leupeptin, and 1 mM 
PMSF), the addition of an ATP regenerating system was omitted and the 
extracts were cleared by two centrifugations at 280,000 g for 40 min at 2°C 
before freezing in liquid nitrogen by 2-ml aliquots. 5 #M taxol (from a  10 
mM stock in DMSO) was added to 20 mi thawed extract and incubated 15 
min at 37°C. The taxol concentration was then raised to 20/zM, and after 
5 rain taxol stabilized brain MTs (5 #M final) were added to the extract. 
After 30 min at room temperature, the extract was loaded on a 40%  su- 
crose cushion prepared in BRB80 (80 mM K-Pipes, 1 mM EGTA,  1 mM 
MgCI2, pH 6.8) with protease inhibitors (1 mM PMSE 2 #g/mi aprotinin, 
pepstatin and teupeptin), 5 #M taxol and 1 mM IYI'T, and centrifuged in 
a SW40 rotor at 80,000 g, 20 min, at 20°C. The pellet was resuspended in 
1/4 of the original extract volume (5 mi) in CM buffer (100 mM K-Pipes, 
0.5 mM EGTA, 2.5 mM MgAc2, pH 7.0) with protease inhibitors, taxol, 
and DTT and centrifuged through a 40%  sucrose cushion as above. The 
resulting pellet, consisting mostly of MAPs and tubulin, was resuspended 
in 1/10 of the original extract volume (2 ml) in CM buffer containing pro- 
tease inhibitors, taxol, DTT, 300 mM NaCI +  10% glycerol, and incubated 
for 30 min at room temperature to elute MAPs. This was then centrifuged 
at  80,000 g  for  30  min at  20°C  in a  TLA100.2 rotor.  The supernatant 
(Smaps) was heated 7  min at 95°C, cooled 5  rain on ice, and then cen- 
trifuged at 100,000 g for 30 min at 4°C in a TLAI00.2 rotor. The superna- 
tant was diluted fourfold with 100 mM piperazine, pH 5.5, 0.25 mg/ml pure 
BSA, protease inhibitors, DTT, and centrifuged in centricon-100 devices at 
1000 g  for 50 min at 4°C in a  Heraeus Labofuge 200.  The concentrated 
volume (1-2 ml) was pooled and loaded on a  Mono-Q PC  1.6/5 SMART 
anion exchange column (Pharmacia LKB Biotechnology, Uppsala, Sweden) 
equilibrated with buffer A (A: 20 mM Piperazine, pH 5.5,  40 mM NaC1, 
protease inhibitors and DTT) at 100 #l/min at room temperature. A linear 
gradient from 0 to 25% B (B: 20 mM Piperazine, pH 5.5,  600 mM NaCI, 
protease inhibitors and DTT) was then performed in 1 ml. The concentra- 
tion of B was linearly increased from 25 to 32 % over 0.5 ml. A step increase 
in the concentration of B was then performed from 32 to 66 % and XMAP- 
230 was immediately eluted from the column. The peak of XMAP230 elu- 
ted in 50/~1 (fraction 24, see Fig. 1 B, lane 7) with an estimated buffer com- 
position of 20 mM Piperazine, pH 5.5,  300 mM NaCI, protease inhibitors 
and DTT. Glycerol was added to the peak fraction (10%  final) and XMAP- 
230 aliquoted by 3 #1 and stored in liquid nitrogen. Nine different prepara- 
tions of this protein were used throughout the work described in this article. 
The volumes and protein concentrations during a preparation of XMAP230 
were typically as follows: the MAPs bound to MTs from 20 ml of a 280,000 g 
interphase egg extract (25-30 mg proteinlml extract) were eluted in 2 ml 
(2-3 mg protein/ml eluate). The purification yield was •25%  as estimated 
by comparing the intensity of the band revealed by immunoblotting of total 
280,000 g extract with known amounts  of pure 230-kD MAP. The peak frac- 
tion from the monoQ column contained 50 to I00 #g of pure XMAP230 
in 50 #1 (corresponding to 4-8 #M).  We estimated the concentration of 
XMAP230 in the eggs to 200-300 nM by western blotting of mitotic extract 
and known amounts of XMAP230 from fraction 24. The staining intensity 
of the blots (probed with L5 and L7) were compared by densitometric scan- 
ning. The relative molecular mass of 230-kD was estimated from a curve 
derived from the mobility of MAP1A (350 k.D), MAP1B (325 kD), MAP2 
(270 kD), and myosin (200 kD) run as markers on 4% SDS-PAGE. Inter- 
phase (activated as described above) and CSF-arrested (mitotic) extracts 
used for MT regrowth off centrosomes and phosphorylation experiments 
were prepared as described by Murray (1991). The HI kinase activities (F6- 
lix et al., 1993) in mitotic and interphase extracts were, respectively, 25 and 
2 pmol/#l/min and the protein concentrations respectively 55 and 45 mg 
protein/ml extract. 
Protein concentrations were measured according to (Bradford,  1976), 
using BSA as a standard. The concentration of pure XMAP230 was mea- 
sured using a  Micro  BCA Protein  Reagent Assay Kit  (Pierce,  BA oud- 
Beijerland,  Holland), and BSA as standard. 
Production of  Monoclonal Antibodies 
Total Xenopus MAPs were prepared as described above and separated on 
preparative 6% SDS-PAGE.  After staining with Coornassie blue, the XMAP- 
230 band was cut and injected into mice (Galfr~,  1981).  Fraction 24 from 
the monoQ column was used for the last injections. The antibodies were 
screened by immunoblot on Xenopus egg extract and by immunofluores- 
cence on Xenopus  cells. We obtained 2 IgG1 (Mouse-Hybridoma-Subtyping 
Kit Boehringer) mAbs named L5 and L7. 
Dissociation Constant and Stoichiometry 
Tubulin (200 #1,  10 mg/ml) precleared by centrifugation at 400,000 g for 
10 min at 4°C in a TLA100 rotor was polymerized by adding taxol (Butner 
and Kirschner, 1991).  XMAP230 (6 #1, 0.8 #M) was diluted in 144 #1 of 
BRB80  containing  1  mM  GTP  and  20  #M  taxol  and  centrifuged  at 
400,000 g for 10 min at 4°C in a TLA100 rotor.  50 p.l of this supernatant 
were mixed with 50 #1 of taxol stabilized MTs, the mixture incubated for 
10 min at  37°C and centrifuged through a  4  M  glycerol cushion under 
preclearing conditions. Supernatant and pellet  were processed for SDS- 
PAGE. The dissociation constant was determined by varying MT polymer 
concentration between 10  -7 and 10  -5 M. The ratio of XMAP230 to tubulin 
polymer concentration never exceeded 1:6 in order not to saturate MTs. To 
determine the stoichiometry of binding, taxol MTs were resuspended at a 
concentration of 4  #M.  They were then mixed with an equal volume of 
buffer containing XMAP230 at increasing concentrations. After a  10-rain 
incubation at 37°C MTs were separated from the MAP by centrifugation 
under pre-clearing conditions. XMAP230 in the supernatants and pellets 
was quantified by densitometric scanning of silver stained gels. 
Iramunofluorescence 
Xenopus XL177 ceils (Miller and Daniel, 1977), were grown in Liebowitz 
L-15 (GIBCO BRL, Gaithersburg, MD) containing 15% FBS, at room tem- 
perature. The cells were seeded on glass coverslips for immunofluorescence 
studies. The cells were fixed in methanol and immunofluorescenee  was ear- 
ried out as previously described (Br~  et al.,  1987).  Primary antibodies: 
Rabbit anti-tubulin Ab raised against the terminal 13 amino acids of tubulin 
(a gift from T. Kreis, University of Geneva, Geneva, Switzerland). The 125 
monoclonal anti-MAP1B antibody (IgM) was a gift from Ulloa et al. (Ulloa 
et al., 1993a,b). The L5 and L7 delipidated ascites were used, respectively, 
1/20  and at  a  1/5,000  dilution.  Secondary antibodies (Dianova GmBH, 
Hamburg,  Germany)  were:  Fluorescein-labeled  donkey  anti-rabbit  and 
Texas red-labeled donkey anti-mouse diluted respectively 1:100 and 1:50. 
Antibodies were diluted in PBS with 3% BSA, 0.05% Triton X-100, 20 mM 
NaN3. 
Video Microscopy 
We used video-enhanced contrast, differential interference contrast (AVEC- 
DIC, Allen et al.,  1981) microscopy to follow MT dynamics as described 
below and in more detail by Chr6tien, D., S.  D.  Fuller, and E.  Karsenti, 
manuscript submitted for publication. 
Homemade observation chambers with a theoretical volume of 10/~1 and 
a total surface area exposed to buffer of ,x,0.25 cm  2 were used. The tubing 
needed for injection increased the actual volume to 25 ~1. The 12-mm round 
glass coverslips used to close the chambers (Fisher Scientific, Pittsburgh, 
PA) were cleaned with ethanol and wiped dry with Kleenex before mount- 
ing. Tubulin was thawed at 37°C and centrifuged at 14,000 g  for 10 min 
at 4°C immediately before use. Tubulin at the desired concentration was 
mixed with centrosomes (,,o3  x  103/#1) at 4°C in an Eppendorf tube and 
then injected into a  chamber followed by 7-min incubation on ice.  The 
chamber was then washed with 300 g,l cold tubulin at the desired concentra- 
tion and placed on the stage of a Zeiss Axiovert 10 photomicroscope (Zeiss 
GmbH, Oberkochen, Germany). Stage, condenser and lens were heated to 
37°C (precise temperature control).  The working temperature inside the 
chamber was 35°C (measured with a thermo-couple). The chamber was in- 
jected with 2.5 #1 of XMAP230 (fraction 24) or 2.5 #1 of control buffer (20 
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started,  vg and vs were estimated by measuring changes in length of in- 
dividual MTs over intervals varying from 1-30 s. The samples were ob- 
served for no longer.than 40 min. In the presence of XMAP230 the mea- 
surement of individual MTs was difficult due to the high number of MTs 
growing from the centrosome and because of increased lateral movement 
as compared to the control; In the presence of XMAP230 v s and vs were 
therefore also measured by the change in radius of the circle formed by the 
ends of the growing MTs (Fig.  7 B); This "bulk  ~ Vg/Vs was equal to the 
Vg/Vs of individual MTs.  For dynamic MTs, the feat was determined by 
dividing the total number of catastrophes observed, by the total time spent 
in the growing phase, vs was determined by depleting the chamber of tubu- 
lin after 20 rain of growth by perfusion of 300/~1 BRB80,  1 mM GTP, 
prewarmed at 35"C. The exchange in the chamber took 10 s, followed by 
immediate injection of either 2.5 ~1 XMAP230 (fraction 24) or 2.5 #1 con- 
trol buffer. 
The microscope and image acquisition were described previously (Verde 
et al.,  1992).  MT dynamics were analyzed on a  Macintosh Quadra 800 
using NIH-Image 1.50 and Kaleidagraph 3.0 programs. 
Calculations 
From the Kd, it is possible to calculate the amount of bound and unbound 
XMAP230 at any concentration of MTs and XMAP230 using the following 
equation in which:  Kd is the molar dissociation constant of XMAP230 
from MTs, mx is the molar concentration of the complex between MTs (m) 
and XMAP230 (x), m is the total molar concentration of MTs and x is the 
total molar concentration of XMAP230: 
mx =  1  (Kd+m  +  x)-  ~1  (Kd  +  m  +  x)  2-  m.x  (1) 
In the experiments reported here, we had ,x,100 centrosomes per chamber. 
If we assume  that each nucleates 100 MTs with a length of 10 ~m, the tubu- 
lin dimer being 8 nm in length and the volume of the chamber 25 t~l, m was 
,'oll pM. The concentration ofx was varied between 0.4 and 0.8 #M. Using 
Eq.  1 we find that the molar concentration of mx must have been between 
0.4 and 0.55 pM in these experiments. This gives a mx:m ratio between 1:2.3 
and 1:1.6. With a stoichiometry (maximum  mx:m ratio) between 1:4 and 1:8 
this means that in our in vitro experiments the MTs were saturated with 
XMAP230. 
Microtubule Spin-down with Pure XMAP230 
Tubulin (5 mg/ml) was centrifuged at 70,000 g  for  10 min at 4°C in a 
TLAI00  rotor.  The  supernatant was diluted  to  3  mg/ml with BRB80- 
glycerol (160 mM Pipes, 2 mM EGTA, 10 mM MgCl2, 1 mM GTP, 66% 
glycerol) and MTs polymerized for 30 rain at 370C. MTs were then diluted 
1:1 with BRBS0-taxul (BRB80 with 20/tM taxol). 2 tzl of pure XMAP230 
(at 6 #M) were added to 8/~1 MTs at 15, 1.5, 0.15/~M final MT concentra- 
tions and incubated 30 min at room temperature. MTs were then fixed for 
10 min with 1 rnl of 0.5% glutaraldehyde in BRBS0 and diluted to 30 pM 
in BRB80. 1 mi of the suspension was spun on coverslips and examined by 
immunofluorescence according to Evans et al.  (1985). 
Preparation of 1Issue Extracts 
Organs were removed from anesthetized frogs at 4°C and transferred to liq- 
uid nitrogen. The organs were pulverized with a mortar in liquid nitrogen 
and Dounce homogenized in CM buffer with protease inhibitors for 1 min 
at 0°C and processed for SDS-PAGE. 
Labeling of  XMAP230 with [?-I~Z]ATP 
1 /~Ci ['y-P32]ATP  was added per/~1 of mitotic and interphase extract. 
Samples were incubated 15 rain at room temperature and then diluted 
with 2 vol XB (Murray, 1991) and immediately boiled 5 min at 95°C, fol- 
lowed by 5 rain on ice. The samples were centrifuged at 100,000 g, 30 min, 
20C in a TLA100 rotor and processed for 2-D gel electrophoresis. 
Gel Electrophoresis and Western Blots 
SDS-PAGE was performed according to the procedure of (Laemmli, 1970) 
using a Mini-Protean II Dual Slab Cell system (Bio Rad Labs., Hercules, 
CA). IEF was performed using a Mini-Protean II 2-D Cell system (Bio Rad 
Labs.). Molecular mass markers were High and Low molecular mass mark- 
ers from Bio Rad Labs. Transfer to nitrocellulose was performed in a semi- 
dry blotting apparatus (Bio Pad Labs.). Blocking, primary and secondary 
antibody incubations were done according to the IntenSE BL (Amersham 
Corp.,  Arlington Heights, IL) enhancement kit.  Fig.  5 B was developed 
using ECL (Amersham Corp.). 
Results 
Purification of  XMAP23O  from Xenopus Egg Extract 
Using  a  mAb directed against rat MAP1B  (Ulloa et al., 
1993a,b) we identified  a 230-kD protein in total Xenopus egg 
extracts  (not  shown).  We  decided  to  purify this  protein 
to further characterize its function. In preliminary experi- 
ments, this protein was found to coprecipitate with MTs after 
addition of  taxol to the extract and to be eluted by 0.3- 0.4 M 
NaC1. We therefore used affinity purification of the 230-kD 
protein on MTs  as a  first step in the procedure.  Fig.  1 A 
shows the proteins that bind to taxol MTs from a 280,000 g 
interphase Xenopus egg  extract under the  conditions de- 
scribed in Materials and Methods. Fig. 1 B shows the puri- 
fication steps. The 230-kD protein is thermostable, and the 
proteins remaining after boiling the eluted MAPs at 95°C are 
shown in Fig. 1 B, lane 4. We followed the 230-kD protein 
during the purification by immunoblotting with the anti- 
MAP1B  mAb (Fig.  1 C).  The MAP1B  antibody strongly 
stained the thermostable 230 kD protein (Fig. 1 C, lane 4), 
which we further purified with anion exchange chromatogra- 
phy (Fig. 1, B and C, lane 7). The pure 230-kD protein was 
still  able  to bind  MTs  as  shown by immunofluorescence 
using the MAP1B mAb (Fig. 1, D and E). It associated with 
MTs along their entire length, and we observed the forma- 
tion of some MT bundles in the presence of this MAP (Fig. 
l, D and E, arrowheads). We estimated the concentration of 
the 230-kD  MAP in eggs at 200-300  nM (Materials and 
Methods). We name the 230-kD MAP, XMAP230 for Xeno- 
pus MAP of 230 kD. 
XMAP230 is Composed of Two Related Isoforms 
While screening mAbs raised against the purified protein, 
we obtained two clones (named L5 and L7), that recognized 
XMAP230 on western blots (data not shown). However, the 
L5 mAb stained a protein of slightly lower apparent molecu- 
lar mass (~230 kD) than the L7 (,,0235 kD) mAb (data not 
shown). This suggested that XMAP230 was not one but at 
least two different proteins or isoforms.  L5 and L7 did not 
recognize phosphorylated epitopes, because treatment of the 
blots by alkaline phosphatase prior to incubation with the an- 
tibodies did not reduce the signal (data not shown); The sig- 
nal  given  by  the  anti-MAP1B  mAb  which  recognizes  a 
phospho-epitope (Ulloa et al,, 1993b) was as expected com- 
pletely abolished (data not shown). These data indicated that 
the L5 and L7 mAbs recognized XMAP230 independently 
of its phosphorylation state. 
A  2-D  gel  electrophoresis  analysis  of XMAP230  con- 
firmed that it was composed of two separate isoforms (Fig. 
2, A and B) having a pI between 4.3 and 4.7 (Fig. 2 B); One 
protein was slightly more acidic and had a slightly higher ap- 
parent molecular mass than the other. The more acidic high 
molecular mass protein was recognized by the L7 whereas 
the other protein was recognized by the L5 mAb only (Fig. 
2 A). Peptide mapping revealed that the L5 and the L7 pro- 
teins were strongly related (data not shown). We will refer 
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lane 2, MAPs eluted from MTs with 300 mM NaCI in CM buffer; lane 3, MAP pellet after 7 min at 95°C;  lane 4, MAP supernatant 
after 7 min at 95°C; lane 5, Centricon-100 flow-through; lane 6, mono-Q column flow-through (two rectangles indicate BSA added before 
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a phosphorylated epitope of rat MAP1B; lane X, total MAP fraction with MTs; The other lanes as in B. D and E XMAP230 binds along 
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to  the  proteins  recognized  by  L5  and  the  L7  mAbs  as 
XMAP230 unless it is essential to make the distinction,  in 
which case we will call them XMAP230a (L7, higher molec- 
ular mass) and XMAP230b  (L5,  lower molecular mass). 
XMAP230 Is Expressed in Eggs, Oocytes, 
Testis and Growing Tissue Culture Cells but 
Not in Non-dividing  Cells 
We tested the expression pattern of XMAP230 in different 
Xenopus tissues using the L5 and the L7 mAbs (Fig. 3, only 
L7 labeling is shown). XMAP230 was only present in eggs, 
oocytes,  testis  and  in  the  XL177  tissue  culture  cell  line 
(Miller and Daniel,  1977).  In brain,  heart,  lung,  stomach 
and muscle, the mAbs recognized a 200-kD protein but not 
XMAP230. The same result was obtained with both antibod- 
ies.  This suggests that the expression of XMAP230  is re- 
stricted to tissues containing cells capable of undergoing fre- 
quent  cell  division  and  that  an  immunologically  related 
protein of lower molecular mass is present in non-dividing 
cells. 
Localization  of  XMAP230 During the Cell Cycle 
We used Xenopus XL177 cells to probe the localization of 
XMAP230 during the cell cycle (Fig. 4). The L5 and the L7 
mAbs gave identical  staining  patterns.  Fig.  4  shows  cells 
probed with the L7 mAb. In prophase, there was a diffuse 
cytoplasmic staining and no MT staining although the MT 
network was still intact (Fig. 4, A-C). However, areas with 
high MT density (like the MTOCs) were stained.  At meta- 
phase/early anaphase XMAP230 was localized to the mitotic 
spindle, but astral MTs were not labeled (Fig. 4, D-F). This 
staining pattern persisted during anaphase (Fig. 4, G-I). In 
telophase, astral MTs and the mid-zone and midbody MTs 
became heavily stained (Fig. 4, J-O). In cells in interphase, 
XMAP230 was localized on the MT network (Fig. 4, P-R). 
XMAP230 is Phosphorylated  and Binds Weakly 
to MTs in Mitotic Egg Extracts 
We thought that hyperphosphorylation could account for the 
dissociation of XMAP230 from MTs in prophase and from 
the astral microtubules during metaphase. To test this,  we 
added  [3,-p32]ATP to interphasic  and mitotic egg extracts, 
heated to remove non-thermostable proteins, and examined 
the phosphorylation level of XMAP230 by 2-D gels and au- 
toradiography. The protein recovered from interphasic ex- 
tracts was clearly resolved in two weakly labeled isoforrns 
(Fig. 5 A, I). The spot seen ,~200-kD on this gel is a con- 
taminant thermostable protein. The protein recovered from 
the mitotic extract was resolved into one strongly labeled 
spot that showed an acidic shift of 0.25 pI units compared 
to the interphasic form of the protein (Fig.  5 A, I and M). 
Both  isoforms were phosphorylated in  the  mitotic extract 
and they migrated close to each other so that it became hard 
to distinguish them (data not shown). XMAP230 was com- 
pletely absent from the pellet of MAPs prepared from mi- 
totic  extracts  and  remained  in  the  supernatant  showing 
a  strong upshift  (Fig.  5  B).  We examined  the  binding  of 
XMAP230 to MTs nucleated by centrosomes in mitotic ex- 
tracts  by immunofluorescence,  using  both the  L5  and  L7 
mAbs.  Single MTs were not stained in the mitotic extract 
although  some  MT  bundles  were.  In  the  interphase  and 
6-DMAP  treated  mitotic  extract  all  MTs  were  strongly 
The Journal of Cell Biology, Volume 127, 1994  1292 Figure 3. Western blot of Xenopus tissues probed with the L7 mAb. 
The samples were run on 6% SDS-PAGE; The same amount of to- 
tal protein was loaded in all lanes. "95C" indicates that the heat sta- 
ble fraction of total protein was loaded in that lane. The position 
of the 200-kD molecular mass marker is indicated. 
Figure 2. XMAP230 is composed of  two polypeptides. (A) Western 
blots of 2-D gels (the second dimension was 6% SDS-PAGE); L5 
indicates staining with the L5 mAb, L7 indicates staining with the 
L7 mAb; 5+7 indicates that the blot was first stained with the L7, 
developed, and then stained with the L5 mAb; The arrowheads la- 
beled 5 and 7 indicate the proteins recognized by the L5 and the 
L7  mAb,  respectively.  (B)  Silver  stained  2-D  gel  (the  second 
dimension was 4% SDS-PAGE) showing the pI of XMAP230 pre- 
pared from extracts in interphase;  The arrowheads labeled 5 and 
7indicate the proteins recognized by the L5 and the L7 mAb respec- 
tively; Ac and Ba indicate, respectively, the acidic and the basic end 
of  the first dimension IEF gel; samples loaded on the gels were from 
the heat stable fraction of a 280,000 g extract supernatant;  the pI 
scale was established using Pharmacia's carbamylated carbonic an- 
hydrase. 
stained (data not shown,  6-DMAP is a non-specific kinase 
inhibitor [Neant and Guerrier,  1988;  Verde et al.,  1990]). 
Stoichiometry of Binding and AjO~nity  for 
Microtubules of  XMAP230 
To determine the stoichiometry of binding of XMAP230 to 
MTs we chose a  concentration of taxol stabilized  MTs of 
2 #M, added increasing concentrations of XMAP230 to the 
suspension and looked for the appearance of XMAP230 in 
the supernatant,  indicating  saturation of the MTs with the 
MAP.  Saturation  occurred  between  0.25  and  0.50  #M 
XMAP230 (Fig.  6 A).  At higher molar ratios, the amount 
of XMAP230 present in the supernatant increased in propor- 
tion to the amount of MAP added. Therefore, saturation oc- 
curred at a molar ratio of XMAP230 to tubulin dimer be- 
tween  1:8 and  1:4 (Fig.  6 A). This is in the same range as 
the ratio reported for tau (1:5)  (Hirokawa et al.,  1988) but 
different from MAP1A (1:12) (Hirokawa et al.,  1988). 
We  also  determined  the  dissociation  constant  (Ko) of 
XMAP230, which is given by the polymer concentration at 
which half of the protein is bound to MTs. As shown in Fig. 
6 B, all the protein was bound to microtubules at 1 #M and 
none at 0.1  #M.  A  closer inspection in the 0.1  and  1.0 #M 
range showed that equimolar distribution between pellet and 
supernatant occurred at 0.5 #M tubulin (data not shown). We 
conclude  that  the  value  of the  Kd  is  close  to  500  mM, 
which is similar to that reported for tau (Butner and Kirsch- 
ner,  1991). 
Effect of  XMAP230 on the Parameters of Microtubule 
Dynamic Instability 
We first examined the effect of XMAP230 on the spontane- 
ous  assembly of bovine  brain  tubulin.  XMAP230  at  the 
highest concentration we could assay (0.8 #M) and at 10 #M 
tubulin  did  not  stimulate  spontaneous  assembly (data  not 
shown). The effect of XMAP230 on microtubule dynamics 
was  then  investigated  on  centrosome-nucleated  MTs  by 
video microscopy. Typical asters produced in this way are 
shown in  Fig.  7  A.  At the  tubulin  concentration  used (11 
ftM), MTs grew at a rate of 1.4 #m/min and showed occa- 
sional catastrophes (Fig. 7 A, bottom).  Addition of XMAP- 
230 at 0.6 #M resulted in an increase in vg by a factor of 2 
to 4 compared to the control MTs, depending on the batch 
of protein used (Fig. 7, A and B and Table I). The concentra- 
tion in the chamber gives the molar ratio of total XMAP230 
to soluble tubulin.  However, the important ratio is that of 
MT bound  XMAP230  to tubulin  polymer.  We calculated 
that MTs were saturated by XMAP230 in these experiments 
(Materials and Methods).  If XMAP'230 was diluted below 
Andersen et al. A 230-kD  MAP in Xenopus Eggs  1293 Figure 4. XMAP230 localization  in XL177 cells during the cell cycle. XL177 cells (Miller  and Daniel,  1977) were stained with: Hoechst 
(A, D, G, J, M, and P), a rabbit anti-tubulin  primary antibody and a secondary FITC conjugated  donkey anti-rabbit antibody (B, E, H, 
K, N, and Q), the L7 mAb as primary and a secondary Texas red conjugated donkey anti-mouse  antibody (C, F, L L, O, and R). Prophase 
(A-C), metaphase/early anaphase  (D-F), anaphase  (G-l), late anaphase  (J-L), telophase  (M-O) and interphase  (P-R).  Bar,  10 #M. Figure 5.  Phosphorylation of XMAP230 and the effect on binding 
to MTs in egg extracts.  (A) Autoradiograms of 2-D gels (the second 
dimension is 4%  SDS-PAGE) of p32-1abeled XMAP230 prepared 
from extracts  in Interphase I and Mitosis M; I is a 7- and M a 2-d 
exposure; The position of the L5 and the L7 isoforms  is indicated 
on both gels.  The acidic end is to the left and the basic end is to 
the right. Samples loaded on the gels were from the heat stable frac- 
tion of a 280,000 g extract supernatant.  (B) Western blot (4% SDS- 
PAGE stained  with both L5 and L7) of MAPs prepared from ex- 
tracts in Interphase,  I or Mitosis,  M; P denotes the MT pellet with 
MAPs and S the remaining supernatant.  Arrow indicates  the 200- 
kD molecular marker.  Note the strong upshift of the protein from 
the mitotic extract.  Bar indicates  the 200-kD molecular marker. 
saturation,  there was no observable effect on MT dynamics 
(data not shown). We conclude that XMAP230 does increase 
vg slightly,  although this is not a  dramatic effect. 
As shown in Fig. 7, pure MTs undergo catastrophic depo- 
lymerization and XMAP230 completely suppressed the oc- 
currence  of such  catastrophes.  However,  since  MTs  also 
grew faster in the presence of XMAP230, it was possible that 
the elimination of catastrophes was due to the higher v 8. To 
test  the  effect of XMAP230  on L,t,  the experiments  were 
repeated  at  similar  vgs.  In  the  presence  of control  buffer 
and  at  10/zM  tubulin,  f~at was 0.47  min  -1  and vg was  1.2 
/zm/min  (Table  II).  At  6  /zM  tubulin  in  the  presence  of 
XMAP230,  vg was  similar  (1.1 /~m/min)  and  f,t  equal  to 
zero (Table II). At 6 #M tubulin,  in the absence of XMAP- 
230,  f~,t was so high that only a  few, very short,  MTs were 
actually observed to grow off centrosomes, making measure- 
ments  difficult  (data  not  shown).  It is  interesting  to  note 
that  many  more  MTs  were  nucleated  in  the  presence  of 
XMAP230 than in its absence (Fig. 7 A and B). This is prob- 
ably due to the suppression of f~at by XMAP230 because we 
also observed this phenomenon under conditions where the 
growth rates were identical  (data not shown). 
Since no catastrophes  were observed in the presence of 
XMAP230,  we could not determine  its effect on vs after a 
spontaneous transition to the shrinkage phase. Walker et al. 
(1991) showed that vs is the same whether induced by dilu- 
tion or by spontaneous transition into the shrinking phase. 
The shrinkage rate was therefore determined after perfusion 
of  buffer into the chamber (see Materials and Methods). MTs 
started to shrink immediately after perfusion (Fig. 8, A and 
B). In the presence of XMAP230 the shrinkage rate was ap- 
proximately 6-fold lower than in the absence of the protein 
(Fig.  8 and Table II). The decrease in vs was dependent on 
the  continuous  presence  of XMAP230  (Fig.  8  B).  MTs 
grown in the presence of XMAP230, and perfused by buffer 
lacking the MAP, had the same vs as control MTs (data not 
shown). This is an expected result in view of the dissociation 
constant of XMAP230 for MTs. 
Figure  6.  Stoichiometry and 
affinity  of  XMAP230  for 
MTs. (A) Stoichiometry; pure 
MTs  (2  /.tM final  concentra- 
tion)  were  incubated  with 
increasing  concentrations  of 
XMAP230  (indicated  below 
the gel) and centrifuged as de- 
scribed in Materials and Meth- 
ods;  XMAP230  saturates 
MTs  at  a  stoichiometry  be- 
tween 1:4 and  1:8. (B) Affin- 
ity;  XMAP230  at  constant 
concentration (16 nM) was in- 
cubated with  MTs at variable 
concentrations (indicated  be- 
low the gel) and centrifuged as 
described  in  Materials  and 
Methods.  S,  supernatant,  P, 
MT pellet.  A and B,  respec- 
tively,  7.5%  and  4-15%  sil- 
ver-stained  gels.  Molecular 
mass markers are indicated. 
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vg (see Table  I).  (A)  Control 
experiment;  MTs  grown  off 
centrosomes in  the  presence 
of 11  tiM tubulin are seen af- 
ter 23 min, 16 s (top left) and 
25  min,  12  s  (middle left) of 
growth;  The  growth,  catas- 
trophe and  shrinkage of one 
representative  MT in that time 
interval,  are  shown  (bottom 
left, arrows 1 and 2  indicate 
this MT  in each panel).  (B) 
MTs grown off  centrosomes  in 
the presence of 11  #M tubu- 
lin  together  with  0.6  /zM 
XMAP230 are seen at 2 min, 
44 s (top right) and 4 min, 3 s 
(middle right);  the growth of 
one representative MT in that 
time interval is shown (bottom 
right).  Bar, 4  #m. 
Table L  Vg Is Increased  Two- to Fourfold in the Presence of XMAP230 
#M tubulin  8  8  8  8  8  11  11 
/zM XMAP230, batch  0.7,I  0.8,II  0.6,III  0.4,IV  C  0.6,III  C 
vs  +  so (/~m/min)  3.5  +  0.3  2.3  +  0.3  1.5  +  0.3  1.9  +  0.3  0.9  +  0.4  4.7  +  0.8  1.4  +  0.3 
No. of MTs  7  8  6  12  11  11  8 
The experiments  were performed with 8 or 11/zM tubulin in a chamber at 35°C with BRB80 +  1 mM GTP (Materials and Methods); the concentration  and batch 
of XMAP230 inside the video chamber is indicated; batch denotes that XMAP230 from different  purifications  was used; C indicates that control buffer was added 
instead of XMAP230; vg is the average growth rate of MTs (measured as indicated in Fig. 7); sd is the standard deviation of the average vs; No. of MTs is the 
number of measured MTs. 
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/~M tubulin  6  10  10  14 
#M  XMAP230,  batch  0.5,V  C  0.5,V  C 
Vg  +  s~ (#rrdmin)  1.1  +  0.3  1.2  :t:  0.2  -  - 
feat (s-')  n.o.  0.008  -  - 
vs +  sd (#m/min)  -  -  1.7  +  0.9  10.5 +  3.0 
No. of MTs  13  16  9  7 
The experiments were performed in a chamber at 35°C with BRB80  +  1 mM GTP (Materials and Methods); the tubulin concentration, concentration and batch 
of XMAP230 inside the video chamber are indicated. In the experiments concerning f=~, MTs were grown at the same growth rate in the presence or absence 
of XMAP230 (see text for more detail) and the ft., values were obtained over a total time of MT growth of 74 min (6 #M tubulin) and 93 min (10 #M tubulin). 
In the experiments concerning v~, MTs were grown until the aster reached a diameter of ,'030 #m in the presence or absence of XMAP230; Shrinkage was then 
induced by perfiasion with buffer, and XMAP230 or control buffer added immediately thereafter (as indicated in Fig. 8 B). sd is the standard deviation of the 
average vg or v~, f,~, is the frequency of catastrophes; n.o.  denotes that no catastrophes were observed; No.  of MTs is the number of measured MTs. 
Discussion 
XMAP230 and Other MAPs 
XMAP230  is  most  likely  the  same  as  the  p220  protein 
purified by Shiina et al. (1992), because we did not find other 
thermostable MAPs in Xenopus egg extract in this molecular 
mass range. Several of our data are nevertheless contradic- 
tory to those of Shiina et al. (1992). These authors reported 
that p220 lowers the critical concentration for spontaneous 
MT assembly, in contrast to our results. Shiina et al. (1992) 
showed that p220 was not localized to MTs during mitosis 
whereas it was present on interphasic MTs.  They also re- 
ported a ubiquitous expression of p220 in Xenopus.  Using 
two mAbs we show that XMAP230  is not only localized 
to  interphase  but also  to  spindle  MTs.  We also find  that 
XMAP230  is  only  present  in  proliferating  cells,  such  as 
eggs, oocytes, testis and XL177 cells although an immuno- 
logically related 200-kD protein is present in other tissues. 
We do not think that this protein is a degradation product of 
XMAP230 because of the method of homogenization used. 
XMAI>230 is clearly different from XMAP215 previously 
purified by Gard and Kirschner (1987),  which is not ther- 
mostable. XMAP230 shares some physical properties with 
MAP4 and an mAb raised against a  thermostable protein 
from HeLa cells that had all the characteristics of MAP4 rec- 
ognized XMAP230b (Faruki and Karsenti,  1994). Further- 
more, the L5 mAb stained spindle MTs in HeLa cells (data 
not shown).  However, four different anti-MAP4 antibodies 
(gift from J. B. Olmsted, University of Rochester, NY) did 
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Figure 8.  XMAP230  decreases  v~.  MTs were  analyzed  during 
shrinkage in the absence (A) and presence (B) of XMAP230; addi- 
tion of XMAP230 denotes that new XMAP230  was added at that 
time point after perfusion with BRB80+ImM GTP; the time be- 
tween shrinkage start and readdition of XMAP230 in B reflects the 
time needed for reinjection of XMAP230. 
not recognize XMAP230.  The appurtenance of these pro- 
teins to the MAP4 family remains therefore open. Although 
anti-MAP1B antibodies recognized XMAP230, peptide map- 
ping revealed that XMAP230 and MAP1B are unrelated (data 
not shown).  Furthermore, MAPIB antibodies stain the cen- 
trosome by immunofluorescence (Domfnguez et al.,  1994) 
whereas the L5 and L7 mAbs do not stain either isolated cen- 
trosomes or centrosomes in cells. 
The effect of XMAP230 on MT dynamics is similar to the 
effect of the brain MAPs,  tau and MAP2 (Drechsel et al., 
1992;  Pryer et al.,  1992).  This similarity suggests that the 
MT binding domain of XMAP230 is similar to that of tau 
and MAP2, a possibility also supported by the fact that they 
all bind to the same carboxy-terminal region of MTs as deter- 
mined by subtilisin cleavage of MTs (data not shown). How- 
ever,  an  important  difference  between  brain  MAPs  and 
XMAP230 is the lack of effect on spontaneous MT assembly 
by the latter. It is possible that the egg contains tau-like pro- 
teins  that  directly  promote  spontaneous  assembly as  ob- 
served in interphase extracts. 
Effect of  XMAP230 on Microtubule Nucleation 
by Centrosomes 
We have noticed two interesting effects of XMAP230 on MT 
nucleation. First, we determined that with the tubulin used 
in  this  study,  the  "critical" tubulin  concentration  for MT 
nucleation off centrosomes is close to 3 #M. At this concen- 
tration, XMAP230 did not facilitate MT growth off centro- 
somes. Using cryo electron microscopy, we have seen that 
MTs start to grow as sheets off the centrosomes before form- 
ing  a  tube  (Chr6tien,  D.,  S.  D.  Fuller,  and  E.  Karsenti, 
manuscript submitted for publication). The lack of effect of 
XMAP230 on the critical concentration for MT nucleation 
off centrosomes may mean that this MAP can bind only to 
fully formed MTs and not to initial  nuclei.  The other in- 
teresting observation is that as soon as the tubulin concentra- 
tion is high enough to support MT growth off centrosomes, 
the number of MTs nucleated is dramatically increased by 
XMAP230.  This is not due to binding of XMAP230 to the 
centrosomes,  as  preincubation  of  the  centrosomes  with 
XMAP230  followed by washing prior to the assay did not 
promote nucleation. The low number of MTs observed in the 
absence of XMAP230 is probably due to the incapacity of 
many MTs  to  reach a  visible length  before undergoing  a 
catastrophe.  Therefore  the  increased  number  of  MTs 
nucleated in the presence of XMAP230 is most likely due 
to  the  MT  stabilizing  activity of XMAP230.  These  data 
confirm directly our previous proposal that soluble factors 
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of MTs actually growing off a centrosome (Br6 and Karsenti, 
1990). 
Localization and Function of XMAP230 
During Mitosis 
It is interesting to note that XMAP230 is localized to all MTs 
in interphase,  seems  to be released  from MTs in prophase 
and reassociates with the mitotic apparatus in metaphase and 
anaphase,  with  the  exception  of  astral  MTs.  Release  of 
XMAP230 from MTs in prophase may be required for disas- 
sembly of the interphase array of MTs. An attractive specula- 
tion  is  that  MAPs  of this type  are  released  from  MTs  in 
prophase to allow the effect of severing  factors which are 
otherwise hindered by the presence of MAPs  (Vale,  1991). 
The reassociation of XMAP230 with the MTs of the mitotic 
spindle seems paradoxical because XMAP230 is phosphor- 
ylated in vivo, and in vitro by cdc2 kinase and MAP kinase, 
and  the  phosphorylated protein  seems  to  have  decreased 
affinity for MTs (this paper and that of Shiina et al.,  1992). 
Even more striking is the complete absence of XMAP230 
from the astral  MTs  during metaphase and anaphase. One 
possible explanation is that XMAP230 is locally less phos- 
phorylated  around the chromosomes,  perhaps  due to  the 
presence of a chromosomal type 1 phosphatase (Fernandez 
et al.,  1992), allowing its specific binding to spindle MTs. 
If we assume that XMAP230 has a function in suppressing 
catastrophes during mitosis, this MAP may have an essential 
function by decreasing  locally the value of fca, around the 
chromosomes leading to a preferential  relative stabilization 
of spindle MTs. This could explain how spindle MTs are sta- 
ble enough to engage in an interaction with kinetochores and 
to form anti-parallel bonds at the spindle equator. Interpolar 
MTs were shown to be very stable (Mastronarde et al., 1993) 
and XMAP230 might be involved in their stabilization and 
crosslinking. 
It is now clear that other non-neuronal MAPs  should be 
identified in this way and their function in MT dynamics and 
in spindle assembly  studied in vitro and by immunodeple- 
tion from egg extracts.  In correlation with phosphorylation 
studies, this will bring the study of spindle morphogenesis 
from phenomenology to molecular characterization of the 
principles at work in this highly complex process. 
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